[{"Assets_0_Q2_USD":9165134000.0,"CIK":"1593034","CommonStockSharesConverted_0_Q2_shares":229798823.0,"CommonStockSharesOutstanding_0_Q2_shares":226802609.0,"Country":"Ireland","EarningsPerShareBasic_1_Q2_USD":0.05,"EarningsPerShareBasic_2_Q2_USD":0.61,"EarningsPerShareDiluted_1_Q2_USD":0.05,"EarningsPerShareDiluted_2_Q2_USD":0.6,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"640358301.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":366888000.0,"NetIncomeLossConverted_1_Q2_USD":10558000.0,"NetIncomeLossConverted_2_Q2_USD":140488000.0,"OfficialName":"Endo International plc Ordinary Shares","RevenuesConverted_1_Q2_USD":687588000.0,"RevenuesConverted_2_Q2_USD":1507993000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquity_0_Q2_USD":-714867000.0,"Ticker":"ENDP","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":233681000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":233348000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":229716000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":228457000.0,"filed":"20200806","footnote":"nan","form":"10-Q","fp":"Q2","fy":"2020.0","name":"ENDO INTERNATIONAL PLC","period":"20200630","qtrs":"1","uom":"USD"}]